GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Days Sales Outstanding

Microba Life Sciences (ASX:MAP) Days Sales Outstanding : 362.83 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Days Sales Outstanding?

Microba Life Sciences's average Accounts Receivable for the six months ended in Dec. 2023 was A$6.51 Mil. Microba Life Sciences's Revenue for the six months ended in Dec. 2023 was A$3.27 Mil. Hence, Microba Life Sciences's Days Sales Outstanding for the six months ended in Dec. 2023 was 362.83.

The historical rank and industry rank for Microba Life Sciences's Days Sales Outstanding or its related term are showing as below:

ASX:MAP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.1   Med: 42.98   Max: 304.48
Current: 304.48

During the past 2 years, Microba Life Sciences's highest Days Sales Outstanding was 304.48. The lowest was 40.10. And the median was 42.98.

ASX:MAP's Days Sales Outstanding is ranked worse than
91.82% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.455 vs ASX:MAP: 304.48

Microba Life Sciences's Days Sales Outstanding increased from Dec. 2022 (167.44) to Dec. 2023 (362.83).

Microba Life Sciences Days Sales Outstanding Historical Data

The historical data trend for Microba Life Sciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Days Sales Outstanding Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Days Sales Outstanding
45.85 40.10

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding - - 167.44 110.54 362.83

Competitive Comparison of Microba Life Sciences's Days Sales Outstanding

For the Diagnostics & Research subindustry, Microba Life Sciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's Days Sales Outstanding falls into.


Microba Life Sciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Microba Life Sciences's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (0.589 + 0.602) / 2 ) / 5.42*365
=0.5955 / 5.42*365
=40.10

Microba Life Sciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.602 + 12.412) / 2 ) / 3.273*365 / 2
=6.507 / 3.273*365 / 2
=362.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences  (ASX:MAP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Microba Life Sciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Days Sales Outstanding
Comparable Companies
ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:GTG ASX:BDX ASX:IBX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX
Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Website
https://www.microba.com
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines